Covid-19 « Science and Enterprise

Trial Shows Broad Coronavirus Immune Response

By Alan, on September 27th, 2023%

Initial results from a clinical trial show an experimental vaccine produces immune responses in healthy adults against Covid-19 variants and a range of other coronaviruses. . . . → Read More: Trial Shows Broad Coronavirus Immune Response

HHS Directs $100M for Covid-19 Venture Investments

By Alan, on August 23rd, 2023%

The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19. . . . → Read More: HHS Directs $100M for Covid-19 Venture Investments

NIH Funding Single Home Test for Covid-19, Influenza, RSV

By Alan, on July 14th, 2023%

A developer of diagnostics for infectious and other diseases is receiving a National Institutes of Health contract to advance a single at-home test for multiple respiratory diseases. . . . → Read More: NIH Funding Single Home Test for Covid-19, Influenza, RSV

Vaccine Patch Shown Safe, Induces Immune Response

By Alan, on June 6th, 2023%

Initial results from a clinical trial show a patch device delivering a Covid-19 vaccine is well tolerated by recipients and triggers a measurable immune response. . . . → Read More: Vaccine Patch Shown Safe, Induces Immune Response

Infographic – More US Support for Childhood Vaccines Than Covid-19

By Alan, on May 27th, 2023%

Bar charts: U.S. opinion on MMR and Covid-19 vaccines

A recent poll shows U.S. adults continue to favor vaccinations against the childhood diseases mumps, measles, and rubella, but show less support for Covid-19 vaccines. . . . → Read More: Infographic – More US Support for Childhood Vaccines Than Covid-19

Low-Dose Covid-19 Vaccine Generates Strong Immune Response

By Alan, on April 27th, 2023%

Ultra-low quantities of an experimental Covid-19 protein vaccine delivered in synthetic cell components are shown in lab animals to generate strong immune responses. . . . → Read More: Low-Dose Covid-19 Vaccine Generates Strong Immune Response

Biotech Gains $53.7M Infectious Disease Test Award

By Alan, on April 21st, 2023%

A maker of diagnostics for infectious diseases is receiving a $53.7 million contract to develop and validate reliable home molecular tests for Covid-19 and flu infections. . . . → Read More: Biotech Gains $53.7M Infectious Disease Test Award

Self-Applied Patch Shown Feasible for Vaccine Delivery

By Alan, on March 31st, 2023%

A clinical trial shows a microneedle patch device for vaccine delivery applied by participants to their own arms works as well in the skin as when administered by clinicians. . . . → Read More: Self-Applied Patch Shown Feasible for Vaccine Delivery

Chewable Covid-19 Drug Reduces Viral Load, Symptoms

By Alan, on March 29th, 2023%

Clinical trial results show an experimental drug given as a chewable tablet reduces viral load and symptoms in people with mild to moderate Covid-19 disease. . . . → Read More: Chewable Covid-19 Drug Reduces Viral Load, Symptoms

Home Infectious Disease Diagnostic Begins Clinical Tests

By Alan, on February 22nd, 2023%

A company offering DNA analysis tests to detect infectious diseases at home and point-of-care is beginning clinical evaluations of its technology. . . . → Read More: Home Infectious Disease Diagnostic Begins Clinical Tests

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise